TY - JOUR
T1 - C-reactive protein levels at admission among stroke patients - A comparative analysis
AU - Koldborg, Alexander Bastian
AU - Sagar, Malini Vendela
AU - Kruuse, Christina
N1 - Copyright © 2025 The Authors. Published by Elsevier B.V. All rights reserved.
PY - 2025/11
Y1 - 2025/11
N2 - OBJECTIVE: Severity and outcome of stroke may be associated with a concomitant or subsequent inflammatory response. C-reactive protein (CRP) may correlate with length of stay (LOS) in hospital, indicating increased complexity of stroke patients with an ongoing inflammatory reaction upon admission.METHODS: This retrospective cross-sectional study used data from admissions to the non-comprehensive Stroke Unit, which receives patients ineligible for revascularization therapy at Herlev-Gentofte hospital, in 2019 and 2020. We extracted data from electronic health records, including age, sex, diagnosis upon discharge (ICD-10), comorbidities, CRP-level, date and time of admission and discharge. CRP-levels were subcategorized as normal (<10 mg/L), moderate elevation (10-40 mg/L) and high elevation (> 40 mg/L). Discharge diagnosis was subcategorized as acute ischemic stroke (AIS), intracerebral hemorrhage (ICH), or transient ischemic attack (TIA). Statistical analyses were performed in R 4.3.3.RESULTS: 2077 patients were included, whereof 1169 had AIS, 831 had TIA and 77 had ICH. 97 had CRP > 40 mg/L, 249 had CRP 10-40 mg/L and 1574 had normal CRP-levels, whereas CRP-levels were unavailable in 157 cases. Our adjusted analysis revealed that CRP-levels > 40 mg/L were associated with longer LOS compared to CRP-levels 0-10 mg/L. No significant association was found between CRP-levels 10-40 mg/L and a longer LOS. Age ≥ 65 years and ICH were associated with prolonged LOS, whereas TIA and COVID-19 lockdown periods were associated with shorter LOS.CONCLUSION: The study demonstrates the potential of CRP as a prognostic marker for increased LOS in hospital among patients with acute stroke or TIA.
AB - OBJECTIVE: Severity and outcome of stroke may be associated with a concomitant or subsequent inflammatory response. C-reactive protein (CRP) may correlate with length of stay (LOS) in hospital, indicating increased complexity of stroke patients with an ongoing inflammatory reaction upon admission.METHODS: This retrospective cross-sectional study used data from admissions to the non-comprehensive Stroke Unit, which receives patients ineligible for revascularization therapy at Herlev-Gentofte hospital, in 2019 and 2020. We extracted data from electronic health records, including age, sex, diagnosis upon discharge (ICD-10), comorbidities, CRP-level, date and time of admission and discharge. CRP-levels were subcategorized as normal (<10 mg/L), moderate elevation (10-40 mg/L) and high elevation (> 40 mg/L). Discharge diagnosis was subcategorized as acute ischemic stroke (AIS), intracerebral hemorrhage (ICH), or transient ischemic attack (TIA). Statistical analyses were performed in R 4.3.3.RESULTS: 2077 patients were included, whereof 1169 had AIS, 831 had TIA and 77 had ICH. 97 had CRP > 40 mg/L, 249 had CRP 10-40 mg/L and 1574 had normal CRP-levels, whereas CRP-levels were unavailable in 157 cases. Our adjusted analysis revealed that CRP-levels > 40 mg/L were associated with longer LOS compared to CRP-levels 0-10 mg/L. No significant association was found between CRP-levels 10-40 mg/L and a longer LOS. Age ≥ 65 years and ICH were associated with prolonged LOS, whereas TIA and COVID-19 lockdown periods were associated with shorter LOS.CONCLUSION: The study demonstrates the potential of CRP as a prognostic marker for increased LOS in hospital among patients with acute stroke or TIA.
KW - Aged
KW - Aged, 80 and over
KW - Biomarkers/blood
KW - C-Reactive Protein/metabolism
KW - Cerebral Hemorrhage/blood
KW - Cross-Sectional Studies
KW - Female
KW - Humans
KW - Ischemic Attack, Transient/blood
KW - Ischemic Stroke/blood
KW - Length of Stay
KW - Male
KW - Middle Aged
KW - Patient Admission
KW - Retrospective Studies
KW - Stroke/blood
UR - https://www.scopus.com/pages/publications/105015094397
U2 - 10.1016/j.clineuro.2025.109142
DO - 10.1016/j.clineuro.2025.109142
M3 - Journal article
C2 - 40915039
SN - 0303-8467
VL - 258
JO - Clinical Neurology and Neurosurgery
JF - Clinical Neurology and Neurosurgery
M1 - 109142
ER -